“The jury’s decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc,” the statement said. It also noted two cases thrown out of New Jersey state court last fall after a judge found inadequate scientific evidence for the suit’s claims.

Imerys also praised the jury’s verdict “for following the science that establishes the safety of talc,” according to a statement attributed to Imerys spokeswoman Gwen Myers. “Imerys sympathizes with women suffering from ovarian cancer and hopes that the scientific community’s efforts will continue to be directed toward finding the true causes of this terrible disease.”

Juror Luke Wilson, 34, of St. Louis, said the jury did not think evidence linking talcum powder with ovarian cancer was strong enough to require Johnson & Johnson to put warning labels on its products.

The lone dissenting juror, George Stair, 76, of St. Louis, disagreed, saying, “I think there was enough [evidence], but obviously I didn’t carry the day. I wish we could have sent a message to Johnson & Johnson to put a warning on the product label.”